Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Gamma-Aminobutyric Acid and Lamotrigine

Research Papers that Mention the Interaction

With long-term dosing and once target doses were achieved at 4 weeks, significant elevations in GABA were observed compared with baseline for all three drugs (topiramate 46%, gabapentin 25%, lamotrigine 25%).
Neurology  •  2002  |  View Paper
Further, GABA (50 mg/kg) and/or muscimol (0.05 mg/kg) pretreatment with sub effective dose gabapentin (50 mg/kg) and lamotrigine (20 mg/kg) significantly potentiated their protective effects which were significant as compared to their effect alone.
European journal of pharmacology  •  2012  |  View Paper
LTG (0.1-300 microM) inhibited the release of aspartate, glutamate and GABA in a concentration-dependent manner.
Neuropharmacology  •  1995  |  View Paper
Tentatively, simultaneous inhibition of GABA (gamma-aminobutyric acid) release might be critically involved in the prodystonic activity of lamotrigine.
European journal of pharmacology  •  1994  |  View Paper
LTG is a less potent inhibitor of the release of γ‐aminobutyric acid ( GABA ), acetylcholine, noradrenaline, and dopamine.
Epilepsia  •  1991  |  View Paper
LTG inhibited veratrine‐evoked release of glutamate and aspartate, with ED50 values of 21 μM for both amino acids, but LTG was less potent in the inhibition of GABA release (ED50= 44 μM).
Epilepsia  •  1986  |  View Paper